virus (EBV)-associated nasopharyngeal carcinoma (NPC) is endemic to southern China and South-East Asia, with the highest incidence observed among the southern Chinese, especially those of Cantonese origin. Unlike other head and neck cancers, NPC features the early invasion of surrounding tissues and metastasis. Moreover, over 60% of NPC cases are first diagnosed with metastasis. 1 Epstein-Barr virus latent membrane protein 1 (LMP1) is associated with malignant functions (eg, proliferation, invasion, and
was associated with positive EBV infection in NPC patients; however, the involvement of Capn4 in LMP1-mediated progression of nasopharyngeal carcinoma and the underlying mechanism(s) have yet to be defined.
In the present study, we sought to investigate the expression of Capn4 induced by LMP1 in NPC and found a significantly positive correlation. Importantly, we uncovered a novel mechanism underlying LMP1-mediated Capn4 activation through ERK/JNK/AP-1 signaling, leading to functional consequences associated with NPC migration.
| MATERIAL S AND ME THODS

| Ethics statement
This research followed the tenets of the Declaration of Helsinki and all subjects provided written informed consent approved by ethics committees of Fujian Medical University prior to their participation in this study and for the use of tissue samples collected before treatment.
| Clinical samples and immunohistochemistry
A total of 153 NPC tissue specimens and clinical pathological data have been described in our previous work. 11 Immunohistochemistry (IHC) for Capn4 and LMP1 was carried out using a Histomouse SP Broad Spectrum DAB kit (Invitrogen-Zymed). Formalin-fixed, paraffin-embedded primary and metastatic NPC sections were deparaffinized and rehydrated. Samples were heated in 10 mmol/L citrate buffer (pH 6.0) for 20 minutes for antigen retrieval. To block endogenous peroxidase activity, sections were incubated with 3% hydrogen peroxide. Sections were then incubated with an anti-Capn4 antibody (Santa Cruz Biotechnology) or anti-LMP1 antibody (DAKO) followed by incubation with a biotinylated secondary antibody. Signal was detected with diaminobenzidine solution. Slides were reviewed and scored independently by two pathologists blinded to the clinical data, using the scoring standard described previously. 12 
| Cell culture, plasmids, and reagents
Both 5-8F and CNE2 cell lines (EBV-negative) were derived from the human NPC cell line, maintained in RPMI-1640 medium (Gibco) supplemented with 10% FBS, and G418 (400 µg/mL; Invitrogen) to select for cells containing the neomycin resistance cassette. Capn4 expression and siRNA plasmids are described in our previous publication. 11 LMP1 mutants containing TM deletion (Δ20-187), C-terminal activation region-1 (CTAR1) deletion (Δ188-231), and CTAR2 deletion (Δ351-386) plasmids were constructed by PCR amplification of LMP1 from pCMV-LMP1-WT (kind gifts from Dr JY Chen) using primers containing BamHI and EcoRI restriction sites. The resulting PCR products were digested with BamHI and EcoRI and cloned in frame into a pCMV-FLAG2 vector (Sigma). SP600125, interfering RNA (con siRNA), c-Fos siRNA, and c-Jun siRNA were purchased from Sigma. PD98059 was purchased from Calbiochem-Novabiochem.
| Western blot analysis
Samples were prepared from whole cell lysates. Total protein was quantified, and equal amounts of protein were separated on SDS-PAGE gels and electrotransferred onto PVDF membranes. The membranes were subsequently probed with primary antibodies, including rabbit polyclonal anti-Capn4 antibody (1:1000; LifeSpan Biosciences), LMP1 monoclonal antibody (CS.1-4, 1:1000; DAKO), as well as anti-MMP2, anti-Snail, and anti-Vimentin antibodies (1:1000, Cell Signaling Technology). Anti-phospho-c-Jun, c-Jun, phospho-c-Fos, c-Fos, phospho-JNK and horseradish peroxidaseconjugated goat antirabbit immunoglobulin antibodies (Santa Cruz Biotechnology) were used as secondary antibodies.
| Luciferase reporter assay
Nasopharyngeal carcinoma cells were transfected with expression plasmids as indicated, together with Capn4 p-Luc2 (or its mutants)
and Renilla as an internal transfection control. An empty vector was used to equalize the total amount of DNA in all transfections.
Cells were collected 24 hours after transfection. Luciferase activity was measured with equal amounts (10% of total for each sample) of protein lysates with the use of a Dual Luciferase Assay kit (Promega) on a multimode microplate reader (Turner Biosystems).
Results represent mean ± standard error (SE) of duplicates for each sample. At least three consistent results were obtained from independent experiments and representative results are shown.
Ability of the empty vector controls to activate the promoter constructs was set to 1.
| Boyden chamber assay
A Matrigel invasion assay was carried out using modified Boyden chambers in 24-well dishes with Transwell filter inserts provided with 8-mm pores (Costar, Fisher Scientific Labosi), as described elsewhere. 13 Invasiveness was determined by counting cells in eight random microscopic fields per well, with each seeded in triplicate.
| Immunofluorescence microscopy
Cells grown on poly-l-lysine-coated cover slides were fixed with 4% formaldehyde, then permeabilized and blocked with 0.1% saponin containing 1% BSA for 20 minutes at room temperature. For actin filament staining, cells were incubated in TRITC-conjugated phalloidin (50 mg/mL; Sigma-Aldrich) for 1 hour after fixation. Nuclei were stained with DAPI (Sigma-Aldrich). All cover slides were mounted with Vectashield reagent (Vector Laboratories Inc.) and visualized by confocal microscopy using a ZEISS LSM510 META laser-scanning confocal microscope (Carl Zeiss). 
| Statistical analysis
| RE SULTS
| Overexpression of Capn4 in EBV-associated NPC
We previously showed that enhanced Capn4 expression was associated with positive EBV infection in NPC patients. 11 EBV is an etiological factor in NPC development and, among the expressed viral genes, LMP1 is detected in most NPC tissues. 1 (Table 1 ). Furthermore, Pearson correlation analysis suggested that Capn4 expression was positively correlated with LMP1 expression in NPC tissues ( Figure 1B ; r = 0.291, P < .001). (Table S1 ).
| Epstein-Barr virus latent membrane protein 1 induces Capn4 expression
To further identify the role of LMP1 in Capn4 expression, we transfected LMP1-expression plasmids into 5-8F and CNE2 NPC cell lines. Western blot analysis showed that LMP1 increased the expression of Capn4 in both cell lines (Figure 2A ). To examine whether LMP1 upregulates Capn4 expression at the transcriptional level, we measured Capn4 transcripts using quantitative reverse transcription-PCR. Results showed that Capn4 transcripts were increased in LMP1-overexpressing cells ( Figure 2B ).
Capn4 promoter assay further showed that LMP1 transcriptionally upregulates the Capn4 promoter in a dose-dependent way ( Figure 2C ). Moreover, compared to the cells transfected with the pCMV2-LMP1 plasmid, 5-8F and CNE2 cells transfected with the pCMV2-LMP1-mutant plasmid showed less activation of the Capn4 promoter ( Figure 2D ). The same result was obtained for
LMP1 expression induced by doxycycline (Dox). LMP1 expression
led to an increase in both Capn4 expression and promoter activation ( Figure 2E and 2). Overall, these data conclusively show that LMP1 is responsible for upregulation of Capn4 expression in NPC cells.
| AP-1 is responsible for LMP1-mediated promoter activity of Capn4
To investigate the specific transcription factors involved in the LMP1-associated enhanced transcriptional activation of Capn4,
TFSEARCH
(https ://www.softp edia.com/get/Scien ce-CAD/ TFSea rch-Viewer.shtml ) was used to evaluate the Capn4 promoter, and a potential AP-1 binding site (−68 to −34 bp) was found. Capn4 promoter activity was significantly decreased when the AP-1 binding site was mutated compared with the wild type (WT) control ( Figure 3A ). It has previously been found that AP-1 is essential for Capn4 promoter activity and gene expression, and that LMP1 can stimulate AP-1 activation to mediate AP-1-dependent transcription in NPC cells. [14] [15] [16] In the present study, the results also indicated that the activation of c-Fos and c-Jun was increased in pCMV2-LMP1 5-8F and CNE2 cells based on the detection of c-Fos and c-Jun phosphorylation ( Figure 3B ). Thus, we assumed that LMP1 might activate the Capn4 promoter by interacting with AP-1. As anticipated, overexpression of LMP1 or stimulation with PMA/ionomycin significantly increased Capn4 promoter activity ( Figure 3C ). Either LMP1 or stimulation with PMA/ionomycin could induce WT Capn4 promoter activity but failed to affect Capn4-mutated promoter activity ( Figure 3D ).
Pretreating cells with curcumin (an AP-1 inhibitor, 10 µmol/L) inhibited LMP1-induced Capn4 expression ( Figure 3E ). Moreover, knockdown of c-Fos and c-Jun significantly reduced the expression of Capn4 ( Figure 3F ), and suppressed Capn4 promoter activity in pCMV2-LMP1-expressing cells ( Figure 3G ).
| Epstein-Barr virus latent membrane protein 1 CTAR1/CTAR2 domains are required for the contribution of AP-1 activation to Capn4 expression
To dissect the functional domains of LMP1 responsible for its in- 
| Epstein-Barr virus latent membrane protein 1 mediates c-Fos and c-Jun activation by ERK/JNK signaling to promote Capn4 expression
AP-1 can be activated by variety of stimuli, including the JNK pathway. 17 Thus, we examined whether LMP1 was able to promote c-Fos activation through the JNK pathway. As shown in Figure 5A , JNK activity was increased in pCMV2-LMP1-expressing cells.
When the cells were treated with SP600125 (a JNK pathway in- 
| Capn4 and LMP1 cooperatively enhance NF-κB activation
It has been well established that LMP1 can regulate NF-κB activation and contributes to tumorigenesis by activating the expression of several genes involved in cellular apoptosis, proliferation, migration, and the immune response. [18] [19] [20] However, we previously reported that NF-κB is a downstream signaling pathway of Capn4
for the promotion of NPC cell migration. 11 To this end, we investigated the molecular functions of Capn4 and LMP1 in NF-κB signaling. The results showed that either the overexpression of Capn4, LMP1, or both could increase the activity of NF-κB, and the coexpression of Capn4 and LMP1 induced a substantial increase in NF-κB activity ( Figure 6A ). In addition, knockdown of Capn4 by RNA interference diminished LMP1-induced NF-κB activation ( Figure 6B ), confirming that Capn4 is essential for LMP1-induced
NF-κB activation. Coexpression or individual expression of Capn4
and LMP1 increased the expression of the NF-κB downstream targets, MMP2, Snail, and vimentin ( Figure 6A ), whereas Capn4 knockdown reduced the induction of NF-κB-mediated gene expression by LMP1 ( Figure 6B ).
| Capn4 coordinates LMP1-induced actin rearrangement and cell motility
To investigate whether LMP1 contributed to cell motility, we conducted Transwell migration assays using NPC cells expressing various forms of LMP1. As shown in Figure 7A , LMP1 expression led to increased cell motility compared with the vector control. Moreover, deletion of the C-terminal cytoplasmic tail, CTAR1 or CTAR2, showed substantially decreased cell motility compared with WT LMP1. To verify the requirement for Capn4
in LMP1-induced cell motility, RNA interference was used to deplete Capn4 from NPC cells, followed by LMP1 overexpression.
As shown in Figure 7B , LMP1 expression in control siRNA cells increased cell motility compared to the vector-transfected cells.
Moreover, knockdown of Capn4 reduced LMP1-induced cell motility by approximately 70%. We next sought to investigate whether the above events are involved in actin rearrangement of NPC cells. As shown in Figure 7C , using phalloidin staining, stress fiber formation was found to be suppressed in NPC cells coexpressing LMP1 and treated with Capn4-specific siRNA, F I G U R E 2 Epstein-Barr virus latent membrane protein 1 (LMP1) induces Capn4 expression in nasopharyngeal carcinoma cells. A, 5-8F and CNE2 cells expressing LMP1 or a control were generated by transfection with different concentrations of pCMV2-LMP1 expression and control plasmids for 24 h, followed by western blot for the level of Capn4 protein expression. B, Level of Capn4 mRNA in 5-8F and CNE2 cells was determined by qRT-PCR. C, Capn4 promoter (−187/+174) activity was examined in cells with different concentrations of pCMV2-LMP1 expression by a reporter assay. Control plasmid was arbitrarily set to 100%. D, Capn4 promoter activity was examined in cells transfected with either pCMV2-LMP1 or pCMV2-LMP1-m. Control plasmid was arbitrarily set to 100%. E, 5-8F and CNE2 cells were treated with 5 g/mL doxycycline (Dox) for 24 h to induce LMP1 expression, and then subjected to immunoblotting analysis to determine the level of Capn4 and LMP1 protein expression. F, Capn4 promoter activity was examined in cells 
| D ISCUSS I ON
We have previously reported that Capn4 functions as an important regulator of NPC cell migration; 11 however, the molecular mechanism by which Capn4 enhances cell migration remains unknown. LMP1 is believed to play a crucial role in the early stages of NPC pathogenesis. [21] [22] [23] [24] In the present study, we sought to elucidate whether Capn4 is involved in LMP1-mediated NPC progression. To investigate the relationship between Capn4 and LMP1 in NPC cells, we examined LMP1 and Capn4 expression in clinical primary and metastatic NPC tissues. Notably, we found that Capn4 and LMP1 were highly expressed in both primary and metastatic NPC tissues with a significantly positive correlation. In addition, overexpression of LMP1 in NPC cell lines resulted in increased Capn4 protein and mRNA expression. Thus, we proposed that LMP1 might upregulate the promoter activity of Capn4.
As expected, we showed that LMP1 could upregulate the activation of the Capn4 promoter. In contrast, Capn4 promoter activity was decreased in NPC cells transfected with a pCMV2-LMP1-mutant plasmid.
Next, we investigated the mechanism by which LMP1 upregulates Capn4 in NPC cells. A previous study found that AP-1 is essential for human Capn4 promoter activity and gene expression. 16 AP-1 transcription factor is an important regulator of several cell signaling pathways, including the expression of downstream genes involved in cell differentiation, survival, proliferation, and migration. [25] [26] [27] [28] Accumulating evidence also suggests that AP-1 plays an important role in promoting NPC cell migration. [29] [30] [31] Furthermore, AP-1 activity has been shown to be mediated by LMP1. 32, 33 Therefore, we speculated that AP-1 activation might be responsible for LMP1induced Capn4 expression. Indeed, we showed that treatment with (amino acid residues 351-386). 22 Both of these domains are required for the ability of LMP1 to mediate the majority of signal transduction events, including NF-κB, JNK, and P38. [35] [36] [37] [38] [39] In the present study, transmembrane domains were found to be dispensable for We next attempted to better understand the mechanism by which LMP1 activates AP-1. Multiple signaling pathways have been related to AP-1 activation. 40, 41 JNK is one of the most important regulators of the complex assembly by c-Fos and c-Jun. 17, [41] [42] [43] Additionally, it has been reported that JNK can be activated by LMP1 and subsequently induce the migration of NPC cells. 36, 37 The present study confirmed this finding in NPC cells that showed that LMP1 sustained the activation of ERK, subsequent c-Fos induction, and binding to AP-1. 14 Another report showed that ERK phosphorylation/activation in breast cancer cells resulted in the rapid upregulation of Capn4 expression. 44 In the present study, we present the role of ERK in LMP1-induced Capn4 expression and AP-1 activity in NPC cells. We found that treatment with an ERK Nuclear factor-κB is a transcription factor that regulates a variety of genes which participate in several crucial physiological processes, including cell survival, inflammation, or immune response. [45] [46] [47] Our prior studies have shown that Capn4-mediated promotion of NPC metastasis occurs through NF-κB activation. 11 A study by Shkoda F I G U R E 7 Activity of Epstein-Barr virus latent membrane protein 1 (LMP1) and Capn4 in nasopharyngeal carcinoma (NPC) cells leads to increased cell motility and actin rearrangement. A, Induction of cell motility by LMP1. CNE2 cells were transfected with the WT-LMP1 plasmid or its truncated forms. After 24 h, the cells were re-seeded for Transwell migration assays as described in Materials and Methods. Images of migrating cells in each experiment were acquired at 200× magnification. B, CNE2 cells were cotransfected with the LMP1 expression plasmid and Capn4 siRNA or an empty vector. After 24 h, the cells were re-seeded for Transwell migration assays as detailed in Materials and Methods. Images of migrating cells in each experiment were acquired at 200× magnification. C, CNE2 cells grown on coverslips were transfected with the plasmid for WT-LMP1 or its truncated forms, or cotransfected with the WT-LMP1 expression plasmid and Capn4 siRNA or pEGFP-N1 vector (pEGFP vector), and then incubated for 48 h. Following 6 h of serum starvation, the cells were fixed and stained with FITC-conjugated phalloidin to examine actin filament (F-actin) arrangement. Images were acquired using a ZEISS LSM510 confocal microscope. Scale bar, 20 mm et al found that LMP1-mediated activation of JNK was dependent on canonical NF-κB, which contributed to the tumorigenicity of EBV-transformed B cells. 36 Our results are consistent with a previous study which found that LMP1 induced a substantial increase in NF-κB activity. However, knockdown of Capn4 by RNA interference diminished LMP1-induced NF-κB activation. It has been reported that NF-κB regulates metastasis-related genes to regulate metastasis in many cancer cells. [48] [49] [50] In the present study, Capn4 was found to be effective at upregulating the expression of MMP2, Snail, and vimentin, which together may have been mediated by NF-κB. Thus, we concluded that LMP1 activated NF-κB through upregulation of Capn4 in NPC cells.
Tumor cell migration is a pivotal step in the process of cancer metastasis. 51, 52 In addition, cellular migration is dependent on the activity of the plasma membrane at the leading edge of the cells, and these membrane structures (eg, actin-based filopodia and lamellipodia) are important structures. Therefore, we are interested in the role of LMP1 in the promotion of filopodia formation. Results of the present study show that exogenous expression of LMP1 in NPC cells substantially enhanced the level of cellular motility and upregulated the formation of stress fibers. Moreover, inhibition of Capn4 by RNA interference substantially blocked LMP1-mediated increase in cell motility and stress fiber formation. Furthermore, deletion of the C-terminal cytoplasmic tails, CTAR1 or CTAR2, also showed substantially decreased cellular motility and stress fiber formation.
Thus, we concluded that LMP1 promotes cell migration by Capn4mediated increase in stress fiber formation.
The findings presented in this study identify a novel mechanism by which LMP1 alters cellular signaling and behavior in NPC cells,
showing the key contribution of Capn4 and the role of the ERK/ JNK/AP-1 signaling pathways. The ability of Capn4 to coordinate with LMP1 to stimulate fibronectin expression and enhance cellular migration suggests a novel role of LMP1-Capn4 in the metastatic process in NPC. 
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